Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches.
Eleid MF, Nkomo VT, Pislaru SV, Gersh BJ.
Annu Rev Med. 2023 Jan 27;74:155-170. doi: 10.1146/annurev-med-042921-122533. Epub 2022 Nov 18.
PMID:36400067
Anticoagulation for rheumatic mitral stenosis, INVICTUS in perspective.
Verma R, Latter DA.
Curr Opin Cardiol. 2023 Mar 1;38(2):55-60. doi: 10.1097/HCO.0000000000001013. Epub 2022 Dec 22.
PMID:36718615
Procedural success and outcomes after percutaneous balloon mitral valvuloplasty in rheumatic mitral stenosis with moderate mitral regurgitation: a retrospective cohort study.
Chichareon P, Nilmoje T, Suwanugsorn S, Chamnarnphol N, Thungthienthong M, Geater SL, Jintapakorn W.
Anticoagulation in Atrial Fibrillation Associated with Mitral Stenosis.
da Silva RMFL.
Cardiovasc Hematol Agents Med Chem. 2022;20(3):172-174. doi: 10.2174/1871525720666220321120944.
PMID:35319395
Quantification of rheumatic mitral stenosis severity with three-dimensional vena contracta area.
Gök G, Çınar T, Sayar N.
Echocardiography. 2019 Feb;36(2):370-375. doi: 10.1111/echo.14213. Epub 2018 Dec 11.
PMID:30548321
Measurement of interatrial septal thickness by echocardiography in patients with moderate to severe rheumatic mitral stenosis undergoing percutaneous balloon mitral valvuloplasty.